There is overwhelming evidence that a transgenic expression of a natural antibody to oxidized phospholipids suppresses lesions in hypercholesterolemic low-density lipoprotein receptor knock out (LDLR−/−) mice, which supports the lipid oxidation hypothesis for atherosclerosis [17]. Here, LDLR is linked to atherosclerosis.